Prostatic Neoplasms: all 6,484 studies
Page 38 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Defining Recurrent Disease With Axumin™Status unknownNCT03996993
- Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate CancerWithdrawnNCT03990194
- Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the BoneStatus unknownNCT03988686Not applicable
- Comparison of Explicit, Implicit and no Values Clarification Decision Aids for Men Considering Prostate Cancer ScreeningStatus unknownNCT03988673Not applicable
- Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the ProstateStatus unknownNCT03987737Not applicable
- Characterize Tumor Hypoxia by Magnetic Resonance ImagingWithdrawnNCT03987568Not applicable
- Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate CancerActive, not recruitingNCT03987386Phase 3
- Resistance Training +/- Creatine for Metastatic Prostate Cancer PatientsCompletedNCT03987217Early Phase 1
- Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Active, not recruitingNCT03983954Phase 1
- Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and CryotherapyStatus unknownNCT03982706
- Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate CancerCompletedNCT03982095
- Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate CancerStatus unknownNCT03979573Not applicable
- The Role of Ga68-PSMA-11 PET Imaging in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyCompletedNCT03977610Not applicable
- Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate CancerActive, not recruitingNCT03976843Phase 2
- Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer SurvivorsCompletedNCT03971591Not applicable
- A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.TerminatedNCT03971110Phase 4
- Focal Therapy for Localized Prostate CancerWithdrawnNCT03970863
- Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRICompletedNCT03967080
- Effect of Treatment on Work Experience in Patients With Stage I-III Prostate CancerCompletedNCT03963739
- Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate CancersStatus unknownNCT03961737Not applicable
- Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate CancerCompletedNCT03961321
- Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate CancerStatus unknownNCT03960788Early Phase 1
- Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as ReferenceCompletedNCT03960112Not applicable
- Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate CancerActive, not recruitingNCT03957252
- Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active SurveillanceCompletedNCT03956108Not applicable
- Organoids From Metastases of Prostate CancerTerminatedNCT03952793Not applicable
- REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate CancerActive, not recruitingNCT03951831Phase 2
- Assessing The Impact Of Incorporating Charlson Comorbidity Scores On Patient Anxiety And SatisfactionCompletedNCT03950180Not applicable
- Urinary and Prostate Microbiotes and Prostate CancerCompletedNCT03947515Not applicable
- Using Virtual Reality (VR) Models for Robotic ProstatectomyCompletedNCT03943368Not applicable
- Upregulation of PSMA Receptors After Androgen Deprivation Therapy on PSMA PET/CT Imaging in Prostate CancerCompletedNCT03938766Not applicable
- Prostate Cancer Detection Rates of Standard Transrectal Prostate Biopsy and MR-guided Fusion Transrectal Prostate BiopsyCompletedNCT03936296Not applicable
- Goserelin 10.8mg Injection in Treatment of Advanced Prostate CancerCompletedNCT03936218Phase 3
- Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion BiopsyStatus unknownNCT03936127Not applicable
- Phase I Study MR-guided SBRT to PCaWithdrawnNCT03935308Not applicable
- Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTROStatus unknownNCT03934164
- High-intensity Focused Ultrasound StudyTerminatedNCT03927924Not applicable
- Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA StudyCompletedNCT03927521Not applicable
- Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side EffectsCompletedNCT03927391Phase 4
- Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate CancerCompletedNCT03927287
- Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate CancerTerminatedNCT03921996Phase 3
- Hypertension Management in Cancer PatientsTerminatedNCT03919214Not applicable
- Reduction of Prostate Biopsy MorbidityCompletedNCT03913039
- Prognostic Factors in Prostate Cancer for Patients Treated by Watchful WaitingActive, not recruitingNCT03912883
- Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese PatientsCompletedNCT03911999
- [18F]PSMA-11 PET/CT Phase 3 Clinical StudyCompletedNCT03911310Phase 3
- A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.CompletedNCT03910660Phase 1/2
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerActive, not recruitingNCT03902951Phase 2
- Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before SurgeryActive, not recruitingNCT03899987Phase 2
- Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).CompletedNCT03896984
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Prostate Cancer in Firemen: Early Diagnosis Because of Increased Diagnostic Pressure?CompletedNCT03896178
- Prostate Cancer Risk in FirefightersStatus unknownNCT03893123
- MRI Prostate for Chinese Men Being Screened for Prostate CancerActive, not recruitingNCT03891732
- Stereotactic Body Radiation Therapy (SBRT) for Prostate CancerActive, not recruitingNCT03889119Not applicable
- The Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate CancerCompletedNCT03888742
- Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03888612Phase 1/2
- MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0)Status unknownNCT03880851Not applicable
- Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate BiopsyCompletedNCT03879486Not applicable
- A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate CancerStatus unknownNCT03879122Phase 2/3
- Safety and Pharmacokinetics of ODM-209CompletedNCT03878823Phase 1/2
- The Effect of ADT on PSMA Expression in Metastatic Prostate CancerStatus unknownNCT03876912Not applicable
- 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT03874884Phase 1
- SBRT in 4 Fractions for Prostate CancerCompletedNCT03873090Not applicable
- A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate CancerCompletedNCT03871816
- Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNCCompletedNCT03870269Not applicable
- Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.TerminatedNCT03869762Phase 2
- Intramuscular Mechanisms of Androgen Deprivation-related SarcopeniaCompletedNCT03867357
- Physical Activity Experiment on Male Prostate Cancer PatientsCompletedNCT03866785Not applicable
- Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate CancerTerminatedNCT03862170Phase 3
- A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid TumorsTerminatedNCT03861403Phase 1
- Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerActive, not recruitingNCT03860272Phase 1
- Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided BiopsyCompletedNCT03859804Not applicable
- The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.Active, not recruitingNCT03857477
- Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) StudyStatus unknownNCT03857113
- Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the ProstateCompletedNCT03853902Not applicable
- 18F-DCFPyL PET-CT Scan and Prostate CancerStatus unknownNCT03852654Phase 2/3
- Mind-Body Health in Uro-Oncology: Research StudyCompletedNCT03852030Not applicable
- Investigating Mindfulness and Music to Ease Radiation Side Effects in Prostate CancerCompletedNCT03852017Not applicable
- Hypofractionated Radiotherapy for Prostate CancerCompletedNCT03851926
- Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL EvaluationStatus unknownNCT03851211
- HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)TerminatedNCT03850795Phase 3
- Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate CancerTerminatedNCT03849365Phase 4
- EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.CompletedNCT03845751Phase 2
- A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate CancerTerminatedNCT03843918Phase 1/2
- The Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Ablation TherapyStatus unknownNCT03838432Not applicable
- Less to Hold - A Comparison of Bladder Toxicities (Side Effects) in Patients Undergoing Prostate Radiotherapy Between Patients Treated With Empty Bladder and Those on a Drinking Protocol.CompletedNCT03832803Not applicable
- Combination of Entinostat and Enzalutamide in Advanced Prostate CancerTerminatedNCT03829930Phase 1
- Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate CancerCompletedNCT03828838Phase 1/2
- Moderately Hypofractionated Radiotherapy for Prostate Cancer.Active, not recruitingNCT03827616Not applicable
- WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgyCompletedNCT03824652Phase 2
- 18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate CancerActive, not recruitingNCT03824275Phase 2/3
- Virtual Prostate Biopsy Protocol for Patients on Active Surveillance and at Risk of Prostate CancerWithdrawnNCT03823001Not applicable
- CyberKnife Dose Escalation Prostate Cancer TrialActive, not recruitingNCT03822494Not applicable
- Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate CancerActive, not recruitingNCT03821792Phase 2
- Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate CancerWithdrawnNCT03817216Not applicable
- A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsCompletedNCT03811652Phase 1
- Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)CompletedNCT03807492
- Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate CancerWithdrawnNCT03800784Phase 2/3
- Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II)Active, not recruitingNCT03795337Not applicable